Veralto Corp Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $5.6B+7.7% YoYTTM through 3 Apr 2026
Net Income $969M+16.3% YoYTTM through 3 Apr 2026
Free Cash Flow $1BTTM through 3 Apr 2026
Margins
| Current | |
|---|---|
| Gross Margin | 59.9% |
| EBITDA Margin | 24.6% |
| Operating Margin | 23.2% |
| Net Margin | 17.3% |
Returns
30.3%ROE
12.2%ROA
22.9%ROIC
Balance Sheet Health
Debt / Equity0.86x
Current Ratio1.67x
Net Debt$642M
Cash & Equivalents$1.4B
Quality Metrics
Altman Z-Score4.81
Piotroski F-Score8 / 9
FCF Margin18.6%
Rule of 4024.3
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $5.5B
Diluted EPS$3.88TTMFY2025: $3.76
Dividend
$0.26Per share, FY20260.27%Yield
Capital Allocation
R&D Spend$270M
Capex Intensity1.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Water Quality | $3.3B | +5.8% | View detailsSteady demand expected to continue, supported by municipal and industrial water treatment needs and the acquisition of In-Situ in early 2026. |
| Product Quality & Innovation | $2.2B | +6.2% | View detailsResilient demand expected from consumer packaged goods and pharmaceutical packaging traceability requirements. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.